Home tumor
 

Keywords :   


Tag: tumor

Rexahn Receives Method Patent For Treatment Of Solid Tumor Cancers For Supinoxin (RX-5902)

2013-12-30 06:54:32| drugdiscoveryonline News Articles

Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing potential best-in-class oncology therapies, recently announced that it has been issued United States Patent, No. 8,598,173, which covers a method for treating solid cancer tumors including ovarian, breast, prostate, liver, lung, kidney, colon, pancreatic and stomach for its clinical development candidate Supinoxin (RX-5902)

Tags: method treatment solid patent

 

Varian's Calypso Tumor Tracking System Used in Lung, Stomach, and Prostate Cancer Treatments ...

2013-09-30 06:00:00| Industrial Newsroom - All News for Today

Lisbon, Portugal &ndash; Clinicians in Lisbon have commenced advanced radiosurgery treatments using Varian's Calypso® 'GPS for the Body' real-time tumor tracking system. Doctors at the 'Champalimaud Center for the Unknown' (CCU) utilized the Calypso system to enhance precision during a radiosurgery treatment that included the world's first clinical use of the new commercially available Calypso lung Beacon® transponder. <br /> <br /> The center has used this method to treat three patients with ...This story is related to the following:Health, Medical and Dental Supplies and EquipmentSearch for suppliers of: Tracking Systems | Radiotherapy Systems |

Tags: system cancer tracking treatments

 
 

Lilly Drug Fails to Meet Survival Goal in Breast Tumor Study

2013-09-27 17:01:44| Food - Topix.net

Eli Lilly & Co.' s experimental drug ramucirumab failed to meet its goals for treating breast cancer in a late-stage trial, sending the shares down.

Tags: meet study goal drug

 

Lilly Drug Fails to Meet Survival Goal in Breast Tumor Study

2013-09-27 02:09:27| Agriculture - Topix.net

Eli Lilly & Co.' s experimental drug ramucirumab failed to meet its goals for treating breast cancer in a late-stage trial, sending the shares down.

Tags: meet study goal drug

 

Merck KGaA brain tumor drug fails clinical trial

2013-02-25 15:33:17| Biotech - Topix.net

Merck KGaA's Cilengitide, an experimental drug to treat an aggressive type of brain tumor, has failed a large-scale clinical trial, dealing a blow to the German drugmaker's efforts to replenish its pipeline of medicines.

Tags: trial drug clinical brain

 

Sites : [1] [2] [3] [4] [5] [6] next »